John West, who earned a Ph.D. in Biological Chemistry from Stanford University, was the CEO of Personalis, Inc. from 2019 until he stepped down in 2022. With a strong background in biotechnology, he co-founded the company and led it through...
John West, who earned a Ph.D. in Biological Chemistry from Stanford University, was the CEO of Personalis, Inc. from 2019 until he stepped down in 2022. With a strong background in biotechnology, he co-founded the company and led it through significant growth phases. During his tenure, he was known for his deep understanding of DNA sequencing and its application in personalized medicine. His compensation reflected his strategic role, with total earnings peaking at around $590,000 in 2021, including a performance bonus linked to company goals like revenue targets. Notably, John engaged in substantial insider trading before his retirement, peaking at an impressive $20.78 million in January 2021. Even after stepping down, he remained a key advisor, leveraging his extensive experience in the field. John's departure marked the end of a significant chapter for Personalis, as he was instrumental in shaping its direction and success in the biotech industry.